Epiminder Funding: How Much Did They Raise & Key Investors

How Much Did Epiminder Raise?
Funding & Key Investors

Epiminder, a medical technology firm, has secured significant enterprise-level funding, with its total capital raised standing at $12.9M. The company recently announced a major strategic investment of $12.9M, underscoring its pivotal role in the epilepsy monitoring sector. This latest financing round, dated October 12, 2020, was classified as a Series A, indicating a phase of scaling and market expansion for the Australian-based innovator.

What is Epiminder?

Epiminder

Manufacturing

Medical Devices & Equipment

Based in Melbourne, Australia, Epiminder is a dedicated medical technology company focused on advancing epilepsy monitoring solutions. The company's core mission revolves around developing and deploying innovative technologies to improve the lives of individuals affected by epilepsy. By concentrating on this critical area of neurological health, Epiminder positions itself as a key player in a specialized segment of the health tech industry, aiming to provide more accurate and accessible monitoring tools.

How much funding has Epiminder raised?

Epiminder has raised a total of $12.9M across 1 funding round:

2020

Series A

$12.9M

Series A (2020): $12.9M, investors not publicly disclosed

What's next for Epiminder?

The recent Series A financing, characterized as a major strategic investment, signals Epiminder's readiness for accelerated growth and market penetration. This capital infusion is expected to fuel the company's research and development initiatives, enhance its product offerings, and expand its operational footprint. With a clear focus on epilepsy monitoring, Epiminder is poised to leverage this backing to solidify its market position and potentially introduce next-generation solutions, further contributing to advancements in neurological care.

See full Epiminder company page

See More Financial Insights